Items where authors include "Woll, P."

Article

Young, R.J., Kirkham, A., Savage, J. et al. (9 more authors) (2025) Selumetinib in combination with anti retroviral therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial. BMC Cancer, 25 (1). 505. ISSN 1471-2407

Woll, P., Gaunt, P., Danson, S. et al. (8 more authors) (2022) Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP) : a randomised, double-blind, placebo-controlled phase II trial. Lung Cancer, 171. pp. 26-33. ISSN 0169-5002

Qin, N., Li, Y., Wang, C. et al. (41 more authors) (2021) Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Frontiers of Medicine, 15 (2). pp. 275-291. ISSN 2095-0217

Bossé, Y., Li, Z., Xia, J. et al. (45 more authors) (2020) Transcriptome‐wide association study reveals candidate causal genes for lung cancer. International Journal of Cancer, 146 (7). pp. 1862-1878. ISSN 0020-7136

Dai, J., Huang, M., Amos, C.I. et al. (36 more authors) (2020) Genome‐wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. International Journal of Cancer, 146 (10). pp. 2855-2864. ISSN 0020-7136

Li, Y., Xiao, X., Bossé, Y. et al. (77 more authors) (2019) Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development. Oncotarget, 10 (19). pp. 1760-1774. ISSN 1949-2553

Ferreiro-Iglesias, A., Lesseur, C., McKay, J. et al. (70 more authors) (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nature Communications, 9 (1). 3927. ISSN 2041-1723

Li, Y., Xiao, X., Han, Y. et al. (73 more authors) (2018) Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis, 39 (3). pp. 336-346. ISSN 0143-3334

McKay, J.D., Hung, R.J., Han, Y. et al. (138 more authors) (2017) Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nature Genetics, 49 (7). pp. 1126-1132. ISSN 1061-4036

Carreras-Torres, R., Johansson, M., Haycock, P.C. et al. (61 more authors) (2017) Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One, 12 (6). e0177875.

Salawu, A., Fernando, M., Hughes, D. et al. (6 more authors) (2016) Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines. British Journal of Cancer. ISSN 0007-0920

Chen, L.S., Baker, T., Hung, R.J. et al. (47 more authors) (2016) Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-analysis. EBioMedicine.

Huang, R., Wei, Y., Hung, R.J. et al. (53 more authors) (2015) Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine, 2 (11). pp. 1677-1685. ISSN 2352-3964

Chen, L-S., Hung, R.J., Baker, T. et al. (53 more authors) (2015) CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis-A Meta-Analysis. JNCI: Journal of the National Cancer Institute , 107 (5). djv100. ISSN 0027-8874

Hakami, F., Darda, L., Stafford, P. et al. (3 more authors) (2014) The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC). British Journal of Cancer, 111 (4). pp. 807-816. ISSN 0007-0920

Zhu, Y., Azahri, N., Yu, D. et al. (1 more author) (2008) Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer, 8 (1). p. 218. ISSN 1471-2407

Proceedings Paper

Marshall, R., Kakoudaki, M., Danson, S.J. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2017) 66: Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum non-pemetrexed doublet chemotherapy. In: Lung Cancer. 15th Annual British Thoracic Oncology Group Conference 2017, 25-27 Jan 2017, Dublin, Ireland. Elsevier , S31-S31.

Kakoudaki, M., Marshall, R., Danson, S.J. orcid.org/0000-0002-3593-2890 et al. (7 more authors) (2017) 67: Outcomes of patients in South Yorkshire who received maintenance pemetrexed treatment for non-squamous, non-small-cell cancer after induction chemotherapy with pemetrexed and cisplatin. In: Lung Cancer. 15th Annual British Thoracic Oncology Group Conference, 25-27 Jan 2017, Dublin, Ireland. Elsevier , S31-S31.